drugset / Trial / NCT00361023

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

NCT00361023

RandomizedParallel-groupOpen-labelTreatment

Summary

Angiotensin type-1 receptor (AT1R) blockers (ARBs) have been recognized recently as regulators of glucose and lipid metabolism in adipocytes and adipose tissue.Moreover telmisartan and irbesartan have been recognized recently as regulators of glucose metabolism. For ARB losartan, the results were controversial. To confirm its effect on glucose metabolism, we designed and performed a prospective, randomized and controlled study in subjects with type 2 diabetes and nephropathy.

Timeline

Start
2006-01
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified